Hugues Charest

7.4k total citations · 2 hit papers
91 papers, 5.2k citations indexed

About

Hugues Charest is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hugues Charest has authored 91 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Epidemiology, 39 papers in Infectious Diseases and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hugues Charest's work include Respiratory viral infections research (40 papers), Influenza Virus Research Studies (36 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Hugues Charest is often cited by papers focused on Respiratory viral infections research (40 papers), Influenza Virus Research Studies (36 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Hugues Charest collaborates with scholars based in Canada, United States and Ivory Coast. Hugues Charest's co-authors include Greg Matlashewski, Alan Sher, Tanya Scharton‐Kersten, Gaston De Serres, Sara Hieny, Caetano Reis e Sousa, Danuta M. Skowronski, Ronald N. Germain, Dragana Janković and Wen‐Wei Zhang and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Hugues Charest

91 papers receiving 5.1k citations

Hit Papers

In Vivo Microbial Stimula... 1997 2026 2006 2016 1997 2007 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. In Vivo Microbial Stimulation Induces Rapid CD40 Ligand–independent Production of Interleukin 12 by Dendritic Cells and their Redistribution to T Cell Areas
    1997 752 citations Caetano Reis e Sousa, Sara Hieny et al. profile →
  2. High Rates of Forward Transmission Events after Acute/Early HIV‐1 Infection
    2007 501 citations Bluma Brenner, Michel Roger et al. The Journal of Infectious Diseases profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Hugues Charest 3.3k 1.6k 1.2k 1.0k 729 91 5.2k
Anders Fomsgaard 1.4k 0.4× 1.5k 0.9× 1.4k 1.3× 245 0.2× 237 0.3× 190 4.8k
Sanjay Gurunathan 1.8k 0.6× 1.0k 0.6× 1.9k 1.6× 932 0.9× 242 0.3× 46 4.4k
Geert van Amerongen 5.8k 1.8× 4.8k 3.0× 2.0k 1.7× 568 0.6× 207 0.3× 160 9.4k
Mark J. Mulligan 3.2k 1.0× 3.6k 2.2× 3.2k 2.8× 1.5k 1.5× 180 0.2× 150 8.5k
Kathy Hancock 2.6k 0.8× 1.0k 0.6× 763 0.7× 300 0.3× 697 1.0× 68 4.7k
Mike Bray 3.1k 1.0× 5.7k 3.5× 1.0k 0.9× 919 0.9× 234 0.3× 96 8.6k
Jens Wrammert 3.2k 1.0× 2.9k 1.8× 2.9k 2.5× 1.5k 1.5× 83 0.1× 81 7.5k
Pathom Sawanpanyalert 1.8k 0.6× 2.1k 1.3× 478 0.4× 876 0.9× 132 0.2× 165 4.0k
Renu B. Lal 1.4k 0.4× 1.7k 1.1× 1.5k 1.3× 337 0.3× 123 0.2× 144 4.4k
Theodore F. Tsai 1.8k 0.6× 3.7k 2.3× 644 0.6× 3.0k 3.0× 657 0.9× 89 6.1k

Countries citing papers authored by Hugues Charest

Since Specialization
Citations

This map shows the geographic impact of Hugues Charest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugues Charest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugues Charest more than expected).

Fields of papers citing papers by Hugues Charest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugues Charest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugues Charest. The network helps show where Hugues Charest may publish in the future.

Co-authorship network of co-authors of Hugues Charest

This figure shows the co-authorship network connecting the top 25 collaborators of Hugues Charest. A scholar is included among the top collaborators of Hugues Charest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugues Charest. Hugues Charest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Charest, Hugues, Judith Fafard, Sara Carazo, et al.. (2023). Timing and Predictors of Loss of Infectivity Among Healthcare Workers With Mild Primary and Recurrent COVID-19: A Prospective Observational Cohort Study. Clinical Infectious Diseases. 78(3). 613–624. 1 indexed citations
2.
Brousseau, Nicholas, Sara Carazo, Geneviève Cadieux, et al.. (2023). Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk. Clinical Infectious Diseases. 78(2). 461–469. 14 indexed citations
3.
Carazo, Sara, et al.. (2023). Influenza Hospitalization Burden by Subtype, Age, Comorbidity, and Vaccination Status: 2012–2013 to 2018–2019 Seasons, Quebec, Canada. Clinical Infectious Diseases. 78(3). 765–774. 4 indexed citations
4.
Raymond, Philippe, et al.. (2022). Detection and Sequencing of Multiple Human Norovirus Genotypes from Imported Frozen Raspberries Linked to Outbreaks in the Province of Quebec, Canada, in 2017. Food and Environmental Virology. 14(1). 40–58. 16 indexed citations
5.
Longtin, Yves, Leighanne Parkes, Hugues Charest, et al.. (2021). Persistence of infectivity in elderly individuals diagnosed with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection 10 days after onset of symptoms: A cross-sectional study. Infection Control and Hospital Epidemiology. 44(4). 659–662. 4 indexed citations
6.
Longtin, Yves, Hugues Charest, Caroline Quach, et al.. (2021). Infectivity of healthcare workers diagnosed with coronavirus disease 2019 (COVID-19) approximately 2 weeks after onset of symptoms: A cross-sectional study. Infection Control and Hospital Epidemiology. 43(1). 102–104. 7 indexed citations
7.
Gilca, Rodica, Marie‐Noëlle Billard, Jesse Papenburg, et al.. (2020). Effectiveness of palivizumab immunoprophylaxis to prevent respiratory syncytial virus hospitalizations in healthy full-term <6-month-old infants from the circumpolar region of Nunavik, Quebec, Canada. Preventive Medicine Reports. 20. 101180–101180. 7 indexed citations
8.
Therrien, Christian, Éric Fournier, Antoinette Ludwig, et al.. (2019). Phylogenetic analysis of West Nile virus in Quebec, Canada, 2004–2016: Co-circulation of distinct variants harbouring conserved amino acid motifs in North America. Virology. 537. 65–73. 3 indexed citations
9.
Doll, Margaret K., David L. Buckeridge, Kathryn Morrison, et al.. (2015). Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting. Vaccine. 33(51). 7307–7314. 17 indexed citations
10.
Skowronski, Danuta M., Naveed Z. Janjua, Gaston De Serres, et al.. (2014). Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses. PLoS ONE. 9(3). e92153–e92153. 312 indexed citations
11.
Janjua, Naveed Z., Danuta M. Skowronski, Gaston De Serres, et al.. (2012). Estimates of Influenza Vaccine Effectiveness for 2007–2008 From Canada's Sentinel Surveillance System: Cross-Protection Against Major and Minor Variants. The Journal of Infectious Diseases. 205(12). 1858–1868. 48 indexed citations
12.
Brenner, Bluma, Matthew Lowe, Daniela Moïsi, et al.. (2011). Subtype diversity associated with the development of HIV‐1 resistance to integrase inhibitors. Journal of Medical Virology. 83(5). 751–759. 59 indexed citations
13.
Launay, É., Philippe Ovetchkine, Léna Coïc, et al.. (2010). Novel influenza A (H1N1): clinical features of pediatric hospitalizations in two successive waves. International Journal of Infectious Diseases. 15(2). e122–e130. 17 indexed citations
14.
Papenburg, Jesse, Mariana Baz, Marie‐Ève Hamelin, et al.. (2010). Household Transmission of the 2009 Pandemic A/H1N1 Influenza Virus: Elevated Laboratory‐Confirmed Secondary Attack Rates and Evidence of Asymptomatic Infections. Clinical Infectious Diseases. 51(9). 1033–1041. 96 indexed citations
15.
Skowronski, Danuta M., Gaston De Serres, Martin Petric, et al.. (2008). Component‐Specific Effectiveness of Trivalent Influenza Vaccine as Monitored through a Sentinel Surveillance Network in Canada, 2006–2007. The Journal of Infectious Diseases. 199(2). 168–179. 89 indexed citations
16.
Aliberti, Júlio, Jesús G. Valenzuela, Vern B. Carruthers, et al.. (2003). Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nature Immunology. 4(5). 485–490. 177 indexed citations
17.
Carvalho, Fernando Aécio de Amorim, Hugues Charest, Carlos Alberto Pereira Tavares, et al.. (2002). Diagnosis of American visceral leishmaniasis in humans and dogs using the recombinant Leishmania donovani A2 antigen. Diagnostic Microbiology and Infectious Disease. 43(4). 289–295. 75 indexed citations
18.
Charest, Hugues, Martha Sedegah, George Yap, et al.. (2000). Recombinant Attenuated Toxoplasma gondii Expressing the Plasmodium yoelii Circumsporozoite Protein Provides Highly Effective Priming for CD8+ T Cell-Dependent Protective Immunity Against Malaria. The Journal of Immunology. 165(4). 2084–2092. 31 indexed citations
19.
Ghedin, Elodie, Hugues Charest, Wen‐Wei Zhang, et al.. (1998). Inducible Expression of Suicide Genes in Leishmania donovani Amastigotes. Journal of Biological Chemistry. 273(36). 22997–23003. 26 indexed citations
20.
Charest, Hugues, Wen‐Wei Zhang, & Greg Matlashewski. (1996). The Developmental Expression of A2 Amastigote-specific Genes Is Post-transcriptionally Mediated and Involves Elements Located in the 3′-Untranslated Region. Journal of Biological Chemistry. 271(29). 17081–17090. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anders Fomsgaard Breakdown of academic impact, for papers by Sanjay Gurunathan Breakdown of academic impact, for papers by Geert van Amerongen Breakdown of academic impact, for papers by Mark J. Mulligan Breakdown of academic impact, for papers by Kathy Hancock Breakdown of academic impact, for papers by Mike Bray Breakdown of academic impact, for papers by Jens Wrammert Breakdown of academic impact, for papers by Pathom Sawanpanyalert Breakdown of academic impact, for papers by Renu B. Lal Breakdown of academic impact, for papers by Theodore F. Tsai
Rankless by CCL
2026